Anebulo Pharmaceuticals's total assets for Q2 2026 were $9.42M, a decrease of -11.95% from the previous quarter. ANEB total liabilities were $1.49M for the fiscal quarter, a 54.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.